1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Biotechnology
Acumen Pharmaceuticals, Inc.

Acumen Pharmaceuticals, Inc.

ABOS
Acumen Pharmaceuticals, Inc.US flagNASDAQ Global Select
2.23
USD
+0.02
- -
135.08MMarket Cap

Income Statement (USD)

APIChatGPT
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
+ Sales & Services Revenue
- -
- -
- -
- -
- -
- -
- -
- Cost of Revenue
- -
- -
- -
- -
- -
- -
- -
+ Cost of Goods & Services
- -
- -
- -
- -
- -
- -
- -
Gross Profit
- -
- -
- -
- -
- -
- -
- -
+ Other Operating Income
- -
- -
- -
- -
- -
- -
- -
- Operating Expenses
8
8
20
45
61
114
124
+ Selling, General & Admin
1
1
7
13
19
20
19
+ Research & Development
9
8
12
32
42
94
105
+ Other Operating Expense
-2
-1
- -
- -
- -
- -
- -
Operating Income (Loss)
-8
-8
-20
-45
-61
-114
-124
- Non-Operating (Income) Loss
- -
-1
81
-2
-9
-12
-2
+ Interest Expense, Net
- -
- -
- -
-2
-10
-10
-3
+ Interest Expense
- -
- -
- -
- -
1
4
4
- Interest Income
- -
- -
- -
2
11
14
7
+ Other Non-Op (Income) Loss
- -
-1
81
- -
1
-1
1
Pretax Income
-8
-7
-101
-43
-52
-102
-121
- Income Tax Expense (Benefit)
- -
- -
- -
- -
- -
- -
- -
- (Income) Loss from Affiliates
- -
- -
- -
- -
- -
- -
- -
Income (Loss) from Cont Ops
-8
-7
-101
-43
-52
-102
-121
- Net Extraordinary Losses (Gains)
- -
- -
- -
- -
- -
- -
- -
+ Discontinued Operations
- -
- -
- -
- -
- -
- -
- -
+ Extraord. & Accounting Changes
- -
- -
- -
- -
- -
- -
- -
Income (Loss) Incl. MI
-8
-7
-101
-43
-52
-102
-121
- Minority Interest
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
-8
-7
-101
-43
-52
-102
-121
- Preferred Dividends
- -
- -
- -
- -
- -
- -
- -
- Other Adjustments
- -
- -
- -
- -
- -
- -
- -
Net Income Avail to Common, GAAP
-8
-7
-101
-43
-52
-102
-121
EBIT
-8
-8
-20
-45
-61
-114
-124
EBITDA
-8
-8
-20
-45
-61
-114
-124
EBITDA Margin (%)
- -
- -
- -
- -
- -
- -
- -
EBITA
-8
-8
-20
-45
-61
-114
-124
Gross Margin (%)
100
- -
- -
- -
- -
- -
- -
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
- -
- -
- -
- -
- -
- -
- -
Sales per Employee
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
Basic Weighted Avg Shares
29
29
20
41
49
60
61
Basic EPS, GAAP
-0.28
-0.26
-5.02
-1.06
-1.08
-1.71
-2
Basic EPS from Cont Ops
-0.28
-0.26
-5.02
-1.06
-1.08
-1.71
-2
Diluted Weighted Avg Shares
29
29
20
41
49
60
61
Diluted EPS, GAAP
-0.28
-0.26
-5.02
-1.06
-1.08
-1.71
-2
Diluted EPS from Cont Ops
-0.28
-0.26
-5.02
-1.06
-1.08
-1.71
-2

Balance Sheet (USD)

APIChatGPT
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Total Current Assets
7
44
199
180
247
178
122
+ Cash, Cash Equivalents & STI
7
44
194
178
244
172
117
+ Cash & Cash Equivalents
7
44
122
130
67
36
54
+ ST Investments
- -
- -
72
48
177
136
63
+ Accounts & Notes Receiv
- -
- -
- -
- -
- -
- -
1
+ Accounts Receivable, Net
- -
- -
- -
- -
- -
- -
- -
+ Notes Receivable, Net
- -
- -
- -
- -
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
- -
- -
- -
+ Other Receivable, Net
- -
- -
- -
- -
- -
- -
1
+ Inventories
- -
- -
- -
- -
- -
- -
- -
+ Raw Materials
- -
- -
- -
- -
- -
- -
- -
+ Work In Process
- -
- -
- -
- -
- -
- -
- -
+ Finished Goods
- -
- -
- -
- -
- -
- -
- -
+ Inventory Adjustments
- -
- -
- -
- -
- -
- -
- -
+ Other Inventory
- -
- -
- -
- -
- -
- -
- -
+ Other ST Assets
1
1
4
3
3
6
5
+ Misc ST Assets
- -
- -
- -
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
Total Noncurrent Assets
- -
- -
32
16
64
61
1
+ Property, Plant & Equip, Net
- -
- -
- -
- -
1
- -
- -
+ Property, Plant & Equip
- -
- -
- -
- -
1
- -
- -
- Accumulated Depreciation
- -
- -
- -
- -
- -
- -
- -
+ LT Investments & Receivables
- -
- -
32
16
63
60
- -
+ LT Investments
- -
- -
32
16
63
60
- -
+ LT Receivables
- -
- -
- -
- -
- -
- -
- -
+ Other LT Assets
- -
- -
- -
- -
- -
- -
- -
+ Total Intangible Assets
- -
- -
- -
- -
- -
- -
- -
+ Goodwill
- -
- -
- -
- -
- -
- -
- -
+ Other Intangible Assets
- -
- -
- -
- -
- -
- -
- -
+ LT Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Assets
- -
- -
- -
- -
- -
- -
- -
Total Assets
7
44
230
197
310
239
123
+ Payables & Accruals
1
1
4
6
8
23
17
+ Accounts Payable
- -
1
1
2
1
6
1
+ Accrued Taxes
- -
- -
- -
- -
- -
- -
- -
+ Interest & Dividends Payable
- -
- -
- -
- -
- -
- -
- -
+ Other Payables & Accruals
1
- -
3
4
7
17
16
+ ST Debt
- -
- -
- -
- -
1
- -
9
+ ST Borrowings
- -
- -
- -
- -
- -
- -
9
+ ST Finance Leases
- -
- -
- -
- -
1
- -
- -
+ Other ST Liabilities
1
6
1
2
4
4
4
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
+ Misc ST Liabilities
1
6
1
2
4
4
4
Total Current Liabilities
1
6
5
8
13
28
30
+ LT Debt
- -
- -
- -
- -
28
29
22
+ LT Borrowings
- -
- -
- -
- -
27
28
22
+ LT Finance Leases
- -
- -
- -
- -
- -
- -
- -
+ Other LT Liabilities
17
57
- -
- -
3
1
- -
+ Accrued Liabilities
- -
- -
- -
- -
- -
- -
- -
+ Pension Liabilities
- -
- -
- -
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Liabilities
17
57
- -
- -
3
1
- -
Total Noncurrent Liabilities
17
57
- -
- -
30
30
22
Total Liabilities
19
63
5
8
43
57
52
+ Preferred Equity and Hybrid Capital
- -
- -
- -
- -
- -
- -
- -
+ Share Capital & APIC
8
8
353
360
489
507
517
+ Common Stock
- -
- -
- -
- -
- -
- -
- -
+ Additional Paid in Capital
8
8
353
360
489
507
517
- Treasury Stock
- -
- -
- -
- -
- -
- -
- -
+ Retained Earnings
-20
-27
-128
-170
-223
-325
-446
+ Other Equity
- -
- -
- -
-1
- -
- -
- -
Equity Before Minority Interest
-11
-19
225
189
267
182
70
+ Minority/Non Controlling Interest
- -
- -
- -
- -
- -
- -
- -
Total Equity
-11
-19
225
189
267
182
70
Total Liabilities & Equity
7
44
230
197
310
239
123
Shares Outstanding
37
39
40
41
58
60
61
Number of Employees
- -
- -
- -
- -
- -
- -
- -
Capital Leases - Total
- -
- -
- -
- -
1
- -
- -
Net Debt
-7
-44
-122
-130
-40
-7
-23
Net Debt to Equity
57.37
235.47
-54.25
-68.92
-14.81
-3.95
-32.41
Tangible Common Equity Ratio
-155.97
-41.84
97.77
96.03
86.08
76.07
57.33
Current Ratio
5.35
6.98
38.6
23.08
19.01
6.46
4.07
Cash Conversion Cycle
- -
- -
- -
- -
- -
- -
- -

Cash Flow Statement (USD)

APIChatGPT
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
12/31/2025
+ Net Income
-8
-7
-101
-43
-52
-102
-121
+ Depreciation & Amortization
- -
- -
- -
- -
- -
- -
- -
+ Non-Cash Items
- -
- -
82
4
5
4
11
+ Stock-Based Compensation
- -
- -
1
3
6
10
10
+ Deferred Income Taxes
- -
- -
- -
- -
- -
- -
- -
+ Asset Impairment Charge
- -
- -
- -
- -
- -
- -
- -
+ Other Non-Cash Adj
- -
-1
81
- -
-1
-5
1
+ Chg in Non-Cash Work Cap
1
- -
- -
4
4
12
-5
+ (Inc) Dec in Accts Receiv
- -
- -
- -
- -
- -
- -
- -
+ (Inc) Dec in Inventories
- -
- -
- -
- -
- -
- -
- -
+ (Inc) Dec in Prepaid Assets
- -
- -
-4
2
- -
-4
1
+ Inc (Dec) in Accts Payable
1
- -
4
3
4
15
-7
+ Inc (Dec) in Other
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
Cash from Operating Activities
-7
-7
-18
-35
-43
-86
-116
+ Change in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
+ Acq of Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
+ Acq of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
- -
+ Acq of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
+ Cash (Repurchase) of Equity
- -
- -
169
4
122
8
- -
+ Increase in Capital Stock
- -
- -
169
4
122
8
- -
+ Decrease in Capital Stock
- -
- -
- -
- -
- -
- -
- -
+ Net Change in LT Investment
- -
- -
-104
39
-172
48
134
+ Dec in LT Investment
- -
- -
- -
81
79
219
172
+ Inc in LT Investment
- -
- -
-104
-42
-251
-171
-38
+ Net Cash From Acq & Div
- -
- -
- -
- -
- -
- -
- -
+ Cash from Divestitures
- -
- -
- -
- -
- -
- -
- -
+ Cash for Acq of Subs
- -
- -
- -
- -
- -
- -
- -
+ Cash for JVs
- -
- -
- -
- -
- -
- -
- -
+ Other Investing Activities
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
Cash from Investing Activities
- -
- -
-104
39
-172
48
134
+ Dividends Paid
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Debt
- -
- -
- -
- -
30
-1
- -
+ Cash From Debt
- -
- -
- -
- -
30
- -
- -
+ Repayments of Debt
- -
- -
- -
- -
- -
-1
- -
+ Other Financing Activities
6
45
32
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
Cash from Financing Activities
6
45
200
4
152
7
- -
Effect of Foreign Exchange Rates
- -
- -
- -
- -
- -
- -
- -
Net Changes in Cash
-1
37
78
8
-63
-31
18
EBITDA
-8
-8
-20
-45
-61
-114
-124
EBITDA Margin (%)
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow
-7
-7
-18
-35
-43
-86
-116
Net Cash Paid for Acquisitions
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow to Firm
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow to Equity
- -
-7
-18
-35
-13
-87
-116
Free Cash Flow per Basic Share
-0.24
-0.26
-0.9
-0.87
-0.89
-1.44
-1.91
Price/Free Cash Flow
- -
- -
-7.57
-6.27
-4.34
-1.2
-1.11
Cash Flow to Net Income
0.86
1.02
0.18
0.82
0.82
0.84
0.95
Capital Expenditures
- -
- -
- -
- -
- -
- -
- -